CMS announces new access to data

The Centers for Medicare & Medicaid Services (CMS) has adopted a new policy that will allow innovators and entrepreneurs to access CMS data, such as Medicare claims. 

Acting CMS Administrator Andy Slavitt made the announcement at Health Datapalooza. The move fits in as part of the administration's commitment to use of data and information to drive transformation of the healthcare delivery system.

“Data is the essential ingredient to building a better, smarter, healthier system. Today's announcement is aimed directly at shaking up healthcare innovation and setting a new standard for data transparency,” said Slavitt. “We expect a stream of new tools for beneficiaries and care providers that improve care and personalize decision-making.”

Patient identity will be protected but providers of care will be revealed. Innovators and entrepreneurs will access data via the CMS Virtual Research Data Center (VRDC) which provides access to granular CMS program data, including Medicare fee-for-service claims data, in an efficient and cost effective manner, according to a release. Researchers working in the CMS VRDC have direct access to approved privacy-protected data files and are able to conduct their analysis within a secure CMS environment.

“Historically, CMS has prohibited researchers from accessing detailed CMS data if they intended to use it to develop products or tools to sell,” said Niall Brennan, CMS chief data officer and director of the Office of Enterprise and Data Analytics. “However, as the delivery system transforms from rewarding volume to value, data will play a key role. We hope that this new policy will lead to additional innovation and insights from the CMS data.”

Examples of tools or products that innovators and entrepreneurs might develop include care management or predictive modeling tools, which could greatly benefit the healthcare system, in the form of healthier people, better quality, or lower cost of care. Even though all data is privacy-protected, researchers also will not be allowed to remove patient-level data from the VRDC. They will only be able to download aggregated, privacy-protected reports and results to their own personal workstation. 

CMS is also announcing today that all researchers will be allowed to request data on a quarterly basis rather than the annual updates that were available in the past. Technological advancements, such as the VRDC, have facilitated access to more current data without higher data costs. This change in data access will allow researchers to conduct more rapid analysis of the delivery system.  

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.